Investors Snag BTAI 6.8% Cheaper Than Its Secondary Stock Offering
July 31, 2020 at 11:27 AM EDT
Looking back to 3 days ago, BioXcel Therapeutics Inc (BTAI) priced a 4,000,000 share secondary stock offering at $50.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..